Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2384-2394

  Galipeau, Jacques ^a   Li, Hewei ^b   Paquin, André ^a   Sicilia, Franca ^a   Karpati, George ^b   Nalbantoglu, Josephine ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING; SUICIDE GENE; VESICULAR STOMATITIS VIRUS; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; BIOTRANSFORMATION; BRAIN NEOPLASMS; CAPSID; GAMMARETROVIRUS; GANCICLOVIR; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; INJECTIONS, INTRALESIONAL; LUMINESCENT PROTEINS; NEOPLASM TRANSPLANTATION; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033563254     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Matthews, T., and Boehme, R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Diseases, 10 (Suppl. 3): S490-S494, 1988.
2. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
3. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst., 82: 297-300, 1990.
4. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors [see comments]. Science (Washington DC), 256: 1550-1552, 1992.
5. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
6. Ishii-Morita, H., Agbaria, R., Mullen, C. A., Hirano, H., Koeplin, D. A., Ram, Z., Oldfield, E. H., Johns, D. G., and Blaese, R. M. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther., 4: 244-251, 1997.
7. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats [see comments]. Cancer Res., 53: 83-88, 1993.
8. Ram, Z., Walbridge, S., Shawker, T., Culver, K. W., Blaese, R. M., and Oldfield, E. H. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg., 81: 256-260, 1994.
9. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., and Vile, R. G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med., 4: 581-587, 1998.
10. Mullen, C. A., Anderson, L., Woods, K., Nishino, M., and Petropoulos, D. Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses. Hum. Gene Ther., 9: 2019-2030, 1998.
11. Chen, S. H., Kosai, K., Xu, B., Pham-Nguyen, K., Contant, C., Finegold, M. J., and Woo, S. L. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res., 56: 3758-3762, 1996.
12. Freeman, S. M., Ramesh, R., and Marrogi, A. J. Immune system in suicide-gene therapy. Lancet, 349: 2-3, 1997.
13. Vile, R. G., Nelson, J. A., Castleden, S., Chong, H., and Hart, I. R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54: 6228-6234, 1994.
14. Ramesh, R., Marrogi, A. J., Munshi, A., Abboud, C. N., and Freeman, S. M. In vivo analysis of the "bystander effect": a cytokine cascade. Exp. Hematol., 24: 829-838, 1996.
15. Gagandeep, S., Brew, R., Green, B., Christmas, S. E., Klatzmann, D., Poston, G. J., and Kinsella, A. R. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect". Cancer Gene Ther., 3: 83-88, 1996.
16. Wei, M. X., Bougnoux, P., Sacre-Salem, B., Peyrat, M. B., Lhuillery, C., Salzmann, J. L., and Klatzmann, D. Suicide gene therapy of chemically induced mammary tumor in rat: efficacy and distant bystander effect. Cancer Res., 58: 3529-3532, 1998.
17. Kianmanesh, A. R., Perrin, H., Panis, Y., Fabre, M., Nagy, H. J., Houssin, D., and Klatzmann, D. A. "Distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor [see comments]. Hum. Gene Ther., 8: 1807-1814, 1997.
18. Iwadate, Y., Namba, H., Tagawa, M., Takenaga, K., Sueyoshi, K., and Sakiyama, S. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration. Oncology, 54: 329-334, 1997.
19. Barba, D., Hardin, J., Sadelain, M., and Gage, F. H. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA, 91: 4348-4352, 1994.
20. Sampson, J. H., Archer, G. E., Ashley, D. M., Fuchs, H. E., Hale, L. P., Dranoff, G., and Bigner, D. D. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. USA, 93: 10399-10404, 1996.
21. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
22. Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., Jr., and Fine, H. A. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med., 3: 1145-1149, 1997.
23. Maron, A., Gustin, T., Le, R. A., Mottet, I., Dedieu, J. F., Brion, J. P., Demeure, R., Perricaudet, M., and Octave, J. N. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Ther., 3: 315-322, 1996.
24. Goodman, J. C., Trask, T. W., Chen, S. H., Woo, S. L., Grossman, R. G., Carey, K. D., Hubbard, G. B., Carrier, D. A., Rajagopalan, S., Aguilar-Cordova, E., and Shine, H. D. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum. Gene Ther., 7: 1241-1250, 1996.
25. Yee, D., McGuire, S. E., Brunner, N., Kozelsky, T. W., Allred, D. C., Chen, S. H., and Woo, S. L. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther., 7: 1251-1257, 1996.
26. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M. and Dorken, B. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther., 4: 9-16, 1997.
27. Hurford, R. K. J., Dranoff, G., Mulligan, R. C., and Tepper, R. I. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat. Genet., 10: 430-435, 1995.
28. Miller, D. G., Adam, M. A., and Miller, A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection (published erratum appears in Mol. Cell. Biol., 12: 433, 1992). Mol. Cell. Biol., 10: 4239-4242, 1990.
29. Kavanaugh, M. P., Miller, D. G., Zhang, W., Law, W., Kozak, S. L., Kabat, D., and Miller, A. D. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA, 91: 7071-7075, 1994.
30. Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., Katz, D., Blaese, R. M., and Oldfield, E. H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells [see comments]. Nat. Med., 3: 1354-1361, 1997.
31. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc. Natl. Acad. Sci. USA, 90: 8033-8037, 1993.
32. Schlegel, R., Willingham, M. C., and Pastan, I. H. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. Journal of Virology, 43: 871-875, 1982.
33. Mastromarino, P., Conti, C., Goldoni, P., Hauttecoeur, B., and Orsi, N. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. Journal of General Virology, 68: 2359-2369, 1987.
34. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. A stable human-derived pack-aging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proceedings of the National Academy of Sciences of the United States of America, 93: 11400-11406, 1996.
35. Morgenstern, J. P., and Land, H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Research, 18: 10681990.
36. Hawley, R. G., Lieu, F. H., Fong, A. Z., and Hawley, T. S. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy, 1: 136-138, 1994.
37. Ghattas, I. R., Sanes, J. R., and Majors, J. E. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Molecular & Cellular Biology, 11: 5848-5859, 1991.
38. Capecchi, M. R. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell, 22: 479-488, 1980.
39. Spencer, H. T., Sleep, S. E., Rehg, J. E., Blakley, R. L., Sorrentino, and BP. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood, 87: 2579-2587, 1996.
40. Hansen, M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunological Methods, 119: 203-210, 1989.
41. Durham, H. D., Alonso-Vanegas, M. A., Sadikot, A. F., Zhu, L., Lochmuller, H., Massie, B., Nalbantoglu, J., and Karpati, G. The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer. Neuro-report, 8: 2111-2115, 1997.
42. Perez-Cruet, M. J., Trask, T. W., Chen, S. H., Goodman, J. C., Woo, S. L., Grossman, R. G., and Shine, H. D. Adenovirus-mediated gene therapy of experimental gliomas. Journal of Neuroscience Research, 39: 506-511, 1994.
43. Namba, H., Iwadate, Y., Tagawa, M., Kimura, M., Shimizu, H., Sato, Sueyoshi, K., and Sakiyama, S. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging. Human Gene Therapy, 7: 1847-1852, 1996.
44. Schlegel, R., Tralka, T. S., Willingham, M. C., and Pastan, I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell, 32: 639-646, 1983.
45. Yee, J. K., Friedmann, T., and Burns, J. C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods in Cell Biology, 43(Pt A): 99-112, 1994.
46. Gallardo, H. F., Tan, C., Ory, D., and Sadelain, M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood, 90: 952-957, 1997.
47. Yee, J. K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J. C., and Friedmann, T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proceedings of the National Academy of Sciences of the United States of America, 91: 9564-9568, 1994.
48. Gaiano, N., Allende, M., Amsterdam, A., Kawakami, K., and Hopkins, N. Highly efficient germ-line transmission of proviral insertions in zebrafish. Proceedings of the National Academy of Sciences of the United States of America, 93: 7777-7782, 1996.
49. Matsubara, T., Beeman, R. W., Shike, H., Besansky, N. J., Mukabayire, Higgs, S., James, A. A., and Burns, J. C. Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae. Proceedings of the National Academy of Sciences of the United States of America, 93: 6181-6185, 1996.
50. Chen, S. T., Iida, A., Guo, L., Friedmann, T., and Yee, J. K. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proceedings of the National Academy of Sciences of the United States of America, 93: 10057-10062, 1996.
51. Yang, Y., Vanin, E. F., Whitt, M. A., Fornerod, M., Zwart, R., Schneiderman, R. D., Grosveld, G., and Nienhuis, A. W. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Therapy, 6: 1203-1213, 1995.
52. Hopkins, N. High titers of retrovirus (vesicular stomatitis virus) pseudotypes, at last [comment]. Proc. Natl. Acad. Sci. USA, 90: 8759-8760, 1993.
53. Diaz, R. M., Eisen, T., Hart, I. R., and Vile, R. G. Exchange of viral promoter/ enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma. J. Virol., 72: 789-795, 1998.
54. Liu, M. L., Winther, B. L., and Kay, M. A. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol., 70: 2497-2502, 1996.
55. Yang, L., Hwang, R., Chiang, Y., Gordon, E. M., Anderson, W. F., and Parekh, D. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin. Cancer Res., 4: 731-741, 1998.
56. Castleden, S. A., Chong, H., Garcia-Ribas, I., Melcher, A. A., Hutchinson, G., Roberts, Hart, I. R., and Vile, R. G. A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model. Hum. Gene Ther., 8: 2087-2102, 1997.